Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department

David Wesley Dowdy, Robert M. Rodriguez, C. Bradley Hare, Beth Kaplan

Research output: Contribution to journalArticle

Abstract

Objectives: Although targeted screening of patients at high risk for human immunodeficiency virus (HIV) infection in the emergency department (ED) improves patient outcomes and may prevent HIV transmission, ED-based screening programs incur additional costs and have thus not been widely scaled up. The objective of this study was to evaluate the cost-effectiveness of ED-based targeted HIV screening as implemented in actual practice. Methods: This was a cost-utility analysis of a rapid HIV screening program in an urban ED. Physicians were encouraged to screen patients undergoing inpatient admission or who had HIV risk factors. The authors measured costs directly and estimated quality-adjusted life expectancy using chart review, literature assumptions, and mathematical modeling. Incremental cost utility was evaluated from a societal perspective using a lifetime time horizon. Results: From June 2008 through September 2009, a total of 3,766 HIV tests were ordered (235 tests per month), of which an estimated 2,406 (64%) represented screening in patients without HIV-related signs or symptoms. Nineteen (0.8%) patients were newly diagnosed through screening during the study period, of whom nine (47%) were eligible for antiretroviral therapy (ART) and maintained consistent outpatient follow-up. Estimated screening costs were $82,300 per year, or $45.53 per screening test, of which $28.01 (62%) was for program management. Targeted screening prevented an estimated 2.1 HIV transmission events over 16 months. Per patient screened, targeted screening saved $112 (95% uncertainty range [UR] = $20 to $225) and resulted in 2.71 quality-adjusted life-days gained (95% UR = 1.71 to 4.01). Cost-utility was most sensitive to the prevalence of undiagnosed HIV in the screened population. Conclusions: Targeted HIV screening, as implemented in an urban ED, is cost saving and increases quality-adjusted life expectancy.

Original languageEnglish (US)
Pages (from-to)745-753
Number of pages9
JournalAcademic Emergency Medicine
Volume18
Issue number7
DOIs
StatePublished - Jul 2011
Externally publishedYes

Fingerprint

Cost-Benefit Analysis
Hospital Emergency Service
HIV
Costs and Cost Analysis
Quality of Life
Life Expectancy
Uncertainty
Virus Diseases
Signs and Symptoms
Inpatients
Outpatients
Physicians
Population

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department. / Dowdy, David Wesley; Rodriguez, Robert M.; Bradley Hare, C.; Kaplan, Beth.

In: Academic Emergency Medicine, Vol. 18, No. 7, 07.2011, p. 745-753.

Research output: Contribution to journalArticle

Dowdy, David Wesley ; Rodriguez, Robert M. ; Bradley Hare, C. ; Kaplan, Beth. / Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department. In: Academic Emergency Medicine. 2011 ; Vol. 18, No. 7. pp. 745-753.
@article{b687294cad7d4016ad3f6cf551df32af,
title = "Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department",
abstract = "Objectives: Although targeted screening of patients at high risk for human immunodeficiency virus (HIV) infection in the emergency department (ED) improves patient outcomes and may prevent HIV transmission, ED-based screening programs incur additional costs and have thus not been widely scaled up. The objective of this study was to evaluate the cost-effectiveness of ED-based targeted HIV screening as implemented in actual practice. Methods: This was a cost-utility analysis of a rapid HIV screening program in an urban ED. Physicians were encouraged to screen patients undergoing inpatient admission or who had HIV risk factors. The authors measured costs directly and estimated quality-adjusted life expectancy using chart review, literature assumptions, and mathematical modeling. Incremental cost utility was evaluated from a societal perspective using a lifetime time horizon. Results: From June 2008 through September 2009, a total of 3,766 HIV tests were ordered (235 tests per month), of which an estimated 2,406 (64{\%}) represented screening in patients without HIV-related signs or symptoms. Nineteen (0.8{\%}) patients were newly diagnosed through screening during the study period, of whom nine (47{\%}) were eligible for antiretroviral therapy (ART) and maintained consistent outpatient follow-up. Estimated screening costs were $82,300 per year, or $45.53 per screening test, of which $28.01 (62{\%}) was for program management. Targeted screening prevented an estimated 2.1 HIV transmission events over 16 months. Per patient screened, targeted screening saved $112 (95{\%} uncertainty range [UR] = $20 to $225) and resulted in 2.71 quality-adjusted life-days gained (95{\%} UR = 1.71 to 4.01). Cost-utility was most sensitive to the prevalence of undiagnosed HIV in the screened population. Conclusions: Targeted HIV screening, as implemented in an urban ED, is cost saving and increases quality-adjusted life expectancy.",
author = "Dowdy, {David Wesley} and Rodriguez, {Robert M.} and {Bradley Hare}, C. and Beth Kaplan",
year = "2011",
month = "7",
doi = "10.1111/j.1553-2712.2011.01110.x",
language = "English (US)",
volume = "18",
pages = "745--753",
journal = "Academic Emergency Medicine",
issn = "1069-6563",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department

AU - Dowdy, David Wesley

AU - Rodriguez, Robert M.

AU - Bradley Hare, C.

AU - Kaplan, Beth

PY - 2011/7

Y1 - 2011/7

N2 - Objectives: Although targeted screening of patients at high risk for human immunodeficiency virus (HIV) infection in the emergency department (ED) improves patient outcomes and may prevent HIV transmission, ED-based screening programs incur additional costs and have thus not been widely scaled up. The objective of this study was to evaluate the cost-effectiveness of ED-based targeted HIV screening as implemented in actual practice. Methods: This was a cost-utility analysis of a rapid HIV screening program in an urban ED. Physicians were encouraged to screen patients undergoing inpatient admission or who had HIV risk factors. The authors measured costs directly and estimated quality-adjusted life expectancy using chart review, literature assumptions, and mathematical modeling. Incremental cost utility was evaluated from a societal perspective using a lifetime time horizon. Results: From June 2008 through September 2009, a total of 3,766 HIV tests were ordered (235 tests per month), of which an estimated 2,406 (64%) represented screening in patients without HIV-related signs or symptoms. Nineteen (0.8%) patients were newly diagnosed through screening during the study period, of whom nine (47%) were eligible for antiretroviral therapy (ART) and maintained consistent outpatient follow-up. Estimated screening costs were $82,300 per year, or $45.53 per screening test, of which $28.01 (62%) was for program management. Targeted screening prevented an estimated 2.1 HIV transmission events over 16 months. Per patient screened, targeted screening saved $112 (95% uncertainty range [UR] = $20 to $225) and resulted in 2.71 quality-adjusted life-days gained (95% UR = 1.71 to 4.01). Cost-utility was most sensitive to the prevalence of undiagnosed HIV in the screened population. Conclusions: Targeted HIV screening, as implemented in an urban ED, is cost saving and increases quality-adjusted life expectancy.

AB - Objectives: Although targeted screening of patients at high risk for human immunodeficiency virus (HIV) infection in the emergency department (ED) improves patient outcomes and may prevent HIV transmission, ED-based screening programs incur additional costs and have thus not been widely scaled up. The objective of this study was to evaluate the cost-effectiveness of ED-based targeted HIV screening as implemented in actual practice. Methods: This was a cost-utility analysis of a rapid HIV screening program in an urban ED. Physicians were encouraged to screen patients undergoing inpatient admission or who had HIV risk factors. The authors measured costs directly and estimated quality-adjusted life expectancy using chart review, literature assumptions, and mathematical modeling. Incremental cost utility was evaluated from a societal perspective using a lifetime time horizon. Results: From June 2008 through September 2009, a total of 3,766 HIV tests were ordered (235 tests per month), of which an estimated 2,406 (64%) represented screening in patients without HIV-related signs or symptoms. Nineteen (0.8%) patients were newly diagnosed through screening during the study period, of whom nine (47%) were eligible for antiretroviral therapy (ART) and maintained consistent outpatient follow-up. Estimated screening costs were $82,300 per year, or $45.53 per screening test, of which $28.01 (62%) was for program management. Targeted screening prevented an estimated 2.1 HIV transmission events over 16 months. Per patient screened, targeted screening saved $112 (95% uncertainty range [UR] = $20 to $225) and resulted in 2.71 quality-adjusted life-days gained (95% UR = 1.71 to 4.01). Cost-utility was most sensitive to the prevalence of undiagnosed HIV in the screened population. Conclusions: Targeted HIV screening, as implemented in an urban ED, is cost saving and increases quality-adjusted life expectancy.

UR - http://www.scopus.com/inward/record.url?scp=79960526373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960526373&partnerID=8YFLogxK

U2 - 10.1111/j.1553-2712.2011.01110.x

DO - 10.1111/j.1553-2712.2011.01110.x

M3 - Article

C2 - 21762236

AN - SCOPUS:79960526373

VL - 18

SP - 745

EP - 753

JO - Academic Emergency Medicine

JF - Academic Emergency Medicine

SN - 1069-6563

IS - 7

ER -